1. |
Leal FE, Premeaux TA, Abdel-Mohsen M, et al. Role of natural killer cells in HIV-associated malignancies. Front Immunol, 2017, 8: 315.
|
2. |
Bonnet F, Lewden C, May T, et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer, 2004, 101(2): 317-324.
|
3. |
Spittle MF. Spectrum of AIDS-associated malignant disorders. Lancet, 1998, 352(9131): 907.
|
4. |
Geocze L, Mucci S, De Marco MA, et al. Quality of life and adherence to HAART in HIV-infected patients. Rev Saude Publica, 2010, 44(4): 743-749.
|
5. |
Weber R, Ruppik M, Rickenbach M, et al. Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Med, 2013, 14(4): 195-207.
|
6. |
Hasse B, Ledergerber B, Furrer H, et al. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis, 2011, 53(11): 1130-1139.
|
7. |
Burkholder GA, Tamhane AR, Appell LE, et al. Short communication: viral suppression is associated with increased likelihood of colorectal cancer screening among persons living with HIV/AIDS. AIDS Res Hum Retroviruses, 2015, 31(5): 519-524.
|
8. |
Deneve JL, Shantha JG, Page AJ, et al. CD4 count is predictive of outcome in HIV-positive patients undergoing abdominal operations. Am J Surg, 2010, 200(6): 694-699.
|
9. |
Chiu CG, Smith D, Salters KA, et al. Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: implications for HAART use and NADM development. BMC Cancer, 2017, 17(1): 270.
|
10. |
Robbins HA, Pfeiffer RM, Shiels MS, et al. Excess cancers among HIV-infected people in the United States. J Natl Cancer Inst, 2015, 107(4): dju503.
|
11. |
Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord; Lewden C, Bouteloup V, et al. All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol, 2012, 41(2): 433-445.
|
12. |
Towner WJ, Xu L, Leyden WA, et al. The effect of HIV infection, immunodeficiency, and antiretroviral therapy on the risk of hepatic dysfunction. J Acquir Immune Defic Syndr, 2012, 60(3): 321-327.
|
13. |
Achhra AC, Petoumenos K, Law MG. Relationship between CD4 cell count and serious long-term complications among HIV-positive individuals. Curr Opin HIV AIDS, 2014, 9(1): 63-71.
|
14. |
中华医学会. 临床诊疗指南-外科学分册. 北京: 人民卫生出版社, 2006: 292-335.
|
15. |
中华医学会感染病学分会艾滋病学组. 艾滋病诊疗指南. 中华传染病杂志, 2006, 24(2): 133-144.
|
16. |
Nabatanzi R, Cose S, Joloba M, et al. Effects of HIV infection and ART on phenotype and function of circulating monocytes, natural killer, and innate lymphoid cells. AIDS Res Ther, 2018, 15(1): 7.
|
17. |
Ni Choileain N, MacConmara M, Zang Y, et al. Enhanced regulatory T cell activity is an element of the host response to injury. J Immunol, 2006, 176(1): 225-236.
|
18. |
刘保池. 艾滋病病毒感染者的围手术期处理. 中华胃肠外科杂志, 2011, 14(7): 494-495.
|
19. |
卢焱, 沈芳. HIV感染者行腹腔镜手术后主要淋巴细胞亚群的变化. 中国艾滋病性病, 2007, 13(3): 207-209.
|
20. |
寸新华, 郑刚, 成永达, 等. HIV感染者行胆囊切除手术后主要淋巴细胞亚群的变化. 昆明医学院学报, 2012, 33(8): 122-124.
|
21. |
邓建宁. HIV感染者行腹腔镜手术对主要淋巴细胞亚群的影响观察. 中国医药导刊, 2014, 16(3): 527-528.
|
22. |
胡明辉, 魏国, 赵勇, 等. 腹腔镜胆囊切除术对 HIV 感染者细胞免疫的影响. 世界华人消化杂志, 2014, 22(5): 700-704.
|
23. |
杨涤, 赵红心, 郜桂菊, 等. HIV/AIDS 手术切口愈合与 CD4+ T 淋巴细胞计数的关系. 中华流行病学杂志, 2014, 35(12): 1333-1336.
|
24. |
Oh HK, Moon SH, Ryoo S, et al. Results of surgical treatment on benign anal diseases in Korean HIV-positive patients. J Korean Med Sci, 2014, 29(9): 1260-1265.
|
25. |
Alfa-Wali M, Tait D, Allen-Mersh T, et al. Colorectal cancer in HIV positive individuals: the immunological effects of treatment. Eur J Cancer, 2011, 47(16): 2403-2407.
|